retatrutide phase 2 weight loss is generating a lot of buzz in the medical world—and for good reason. As research continues, many experts believe it could represent the next generation of metabolic health treatments The summary of phase 2

Med (Baltimore)

52,53 In a phase 2, multi-center trial conducted at 45 centers, orforglipron at doses of 12 mg or greater showed significant reductions in HbA1c and bodyweight compared with placebo or dulaglutide

MPMs Singapore team is literally screening through thousands of assets that are coming out of China, Bardon says

The same receptor signaling that slows gastric emptying also reduces motility throughout your entire gastrointestinal tract

The letter was part of a broader March 2026 FDA sweep that named more than 30 telehealth companies over compounded GLP-1 marketing practices, so this was an industry-wide compliance issue rather than an isolated scandal